Stock listing

LS Exchange:A2PZG1 Precigen, Inc. Aktie

German listing (LS Exchange) of Precigen, Inc. · home listing NASDAQ:PGEN

Follow Precigen, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:PGEN

$6.39 USD -0.81 (-11.3%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PGEN

Since Jul 6, 2026 +14.0% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$6.31 – $7.22 USDOct 16, 2026
Volume
5.48M sharesOct 16, 2026
Market value
$2.27B USDAt the close on Oct 16, 2026 · price × 356.2M shares outstanding
Precigen, Inc. logo
Ticker
LS Exchange:A2PZG1
Asset type
Stock
Exchange
LS Exchange
Currency
EUR

What changed lately

Calls

Replays

  • Precigen (NASDAQ:PGEN) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 4:30 PM ET

    Watch Transcript

  • Precigen (NASDAQ:PGEN) Q1 2026 Earnings Call

    Wed, May 13, 2026 · 4:30 PM ET

    Watch Transcript

  • Precigen (NASDAQ:PGEN) Q4 2025 Earnings Call

    Wed, Mar 25, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform

Sep 21, 2026

Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth

Aug 4, 2026

Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4

Jul 21, 2026

Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging

Jun 15, 2026

Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices

Jun 11, 2026

Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years

May 30, 2026

Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States

May 27, 2026

Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference

May 26, 2026

Precigen Reports First Quarter 2026 Financial Results and Business Updates

May 13, 2026

Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13

May 7, 2026

All Precigen, Inc. news

Decks

Precigen, Inc. on 6ix

News releases
18 in the last 12 months · 172 in all · newest Sep 21, 2026 · oldest 2019
Calls
14 calls with a replay · 14 with a transcript · latest Aug 4, 2026
Decks
34 decks · latest May 13, 2026

Where Precigen, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:PGEN · Home listingNASDAQUnited StatesUSD
gettex:I5XgettexGermanyEUR
Lang & Schwarz:A2PZG1Lang & SchwarzGermanyEUR
LS Exchange:A2PZG1 · This pageLS ExchangeGermanyEUR
Tradegate:I5XTradegateGermanyEUR
BOATS:PGENBOATSUnited StatesUSD
Frankfurt:I5XFrankfurtGermanyEUR
BX Swiss:I5XBX SwissSwitzerlandCHF
Dusseldorf:I5XDusseldorfGermanyEUR
Hamburg:I5XHamburgGermanyEUR
Munich:I5XMunichGermanyEUR
Stuttgart:I5XStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Precigen, Inc.